APLN and diabetes mellitus: In conclusion, the present study has shown that once daily administration of (Lys8gluPAL)apelin-13 amide or pGlu(Lys8gluPAL)apelin-13 amide ameliorated diabetes, evoked weight loss and decreased circulating lipids in high-fat fed mice, with effects similar to or better than liraglutide.